
|Articles|November 1, 1999
Supplements and Featured Publications
- The Clinical and Economic Impact of Pneumococcal Disease in the Pediatric Population
- Volume 5
- Issue 17 Suppl
Selected Abstracts
Advertisement
Articles in this issue
over 26 years ago
Participating Facultyover 26 years ago
Introductionover 26 years ago
Epidemiology of Pneumococcal Diseaseover 26 years ago
The Costs of Antimicrobial Treatment Failure in Acute Otitis Mediaover 26 years ago
Prevention of Pneumococcal Disease in High-Risk Pediatric Groupsover 26 years ago
The Clinical Impact of Pneumococcal Conjugate Vaccinesover 26 years ago
Economic Impact of Pneumococcal Conjugate Vaccine in Managed Careover 26 years ago
Into the Era of the Pneumococcal Conjugate Vaccineover 26 years ago
CME Quizover 26 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads
2
TrumpRx Launch Brings Savings—and Uncertainty
3
MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS
4
Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again
5










